GO:0070679 inositol 1,4,5 trisphosphate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070679 defines the molecular function of binding to inositol 1,4,5 trisphosphate (IP3), a calcium-mobilizing second messenger.
• IP3 binding is mediated primarily by IP3 receptors (ITPR1, ITPR2, ITPR3), which are ligand-gated calcium channels on the endoplasmic reticulum.
• The binding event triggers conformational changes that open the channel, releasing Ca2+ into the cytoplasm and regulating diverse cellular processes.
• IP3 binding affinity and specificity are modulated by ATP, Ca2+, phosphorylation, and other cellular factors.
• Dysregulation of IP3 binding and signaling is implicated in cancer, neurodegeneration, and cardiovascular disorders.
• CRISPR-based models (knockout, point mutation, knock-in) enable precise dissection of IP3 binding domains and their physiological roles.
Description
Inositol 1,4,5 trisphosphate (IP3) binding is a molecular function that mediates the primary release of calcium from intracellular stores in response to extracellular signals. This function is essential for translating phospholipase C activation into cytoplasmic Ca2+ signals that control fertilization, secretion, muscle contraction, gene expression, and cell death. The Gene Ontology term GO:0070679 captures the binding activity of proteins that recognize IP3, most notably the IP3 receptor family (ITPR1, ITPR2, ITPR3). Researchers study IP3 binding to understand how cells decode calcium signals and how defects in this process contribute to disease. Because IP3 binding is the first step in a ubiquitous signaling cascade, it is a focal point for both basic cell biology and therapeutic development.
inositol 1,4,5 trisphosphate binding At A Glance
| GO ID | GO:0070679 |
|---|---|
| GO term | inositol 1,4,5 trisphosphate binding |
| Ontology | molecular_function |
| Synonym | InsP3 binding, IP3 binding |
| Major function | Binding to inositol 1,4,5 trisphosphate, leading to calcium release from intracellular stores |
| Major proteins | ITPR1, ITPR2, ITPR3, and other IP3-binding proteins |
| Cellular location | Endoplasmic reticulum membrane, other intracellular membranes |
| Associated process | Calcium signaling, signal transduction |
| Disease relevance | Cancer, neurodegeneration, cardiovascular disorders |
What Is GO:0070679?
GO:0070679 (inositol 1,4,5 trisphosphate binding) is a molecular function defined as the binding to inositol 1,4,5 trisphosphate (IP3). This term describes the selective, non-covalent interaction between a protein and IP3, a soluble second messenger produced by phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate. The binding event is typically reversible and occurs at a specific ligand-binding pocket within IP3 receptors and other IP3-binding proteins.
Why Is inositol 1,4,5 trisphosphate binding Important in Cell Biology?
IP3 binding is a central node in calcium signaling, a process that controls nearly every aspect of cellular life. The binding of IP3 to its receptors triggers the release of Ca2+ from the endoplasmic reticulum, which in turn regulates processes as diverse as cell proliferation, differentiation, apoptosis, and synaptic plasticity. Because calcium signals must be tightly controlled, defects in IP3 binding or downstream signaling contribute to a wide range of pathologies, including cancer, neurodegenerative diseases, and heart failure. Understanding the molecular details of IP3 binding is therefore critical for developing targeted therapies that modulate calcium signaling.
• IP3 binding is the primary mechanism for mobilizing intracellular calcium in response to many hormones and neurotransmitters.
• It is essential for fertilization, cell proliferation, and differentiation.
• Dysregulated IP3 binding contributes to cancer progression and metastasis.
• Altered IP3 binding is linked to neurodegenerative disorders such as Alzheimer's and Huntington's diseases.
• IP3 binding regulates cardiac contractility and vascular tone.
• It plays a key role in immune cell activation and inflammatory responses.
• IP3 binding is a target for drug discovery, with modulators being explored for therapeutic use.
• CRISPR-based editing of IP3 receptor genes enables precise functional studies.
Molecular Mechanism of inositol 1,4,5 trisphosphate binding
Ligand recognition and binding pocket
In simple terms: IP3 fits into a specific pocket on the receptor protein like a key in a lock.
The IP3-binding domain of IP3 receptors is located in the N-terminal region and forms a pocket that specifically recognizes the inositol ring and phosphate groups of IP3. Affinity chromatography studies have shown that IP3 binds with high affinity and specificity to these receptors. The binding pocket is highly conserved among IP3 receptor isoforms, but subtle differences contribute to isoform-specific properties.
Conformational change and channel opening
In simple terms: When IP3 binds, the receptor changes shape and opens a channel to let calcium out.
Binding of IP3 induces a conformational change in the receptor that leads to the opening of the calcium channel pore. This process is regulated by calcium itself, with low concentrations enhancing opening and high concentrations inhibiting it. The conformational dynamics have been studied using fluorescent ligand assays and structural techniques.
Calcium release and signal propagation
In simple terms: Calcium ions flow out of the endoplasmic reticulum into the cytoplasm, spreading the signal.
Once the channel opens, Ca2+ flows down its concentration gradient from the endoplasmic reticulum lumen into the cytoplasm. This initial release can trigger further Ca2+ release through calcium-induced calcium release, generating complex spatiotemporal patterns such as waves and oscillations. These signals are decoded by downstream effectors to control diverse cellular responses.
Regulation by cofactors and post-translational modifications
In simple terms: Other molecules and chemical tags can tune how well IP3 binds and how strongly the channel opens.
IP3 binding and channel activity are modulated by ATP, which increases the open probability, and by phosphorylation by kinases such as PKA and PKC. Redox modifications and interacting proteins also influence receptor function. These regulatory mechanisms allow fine-tuning of calcium signals in different cell types.
Key Genes Involved in GO:0070679 inositol 1,4,5 trisphosphate binding
The following genes encode proteins that bind IP3 or are directly involved in IP3-mediated calcium signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITPR1 | IP3 receptor type 1, forms IP3-gated calcium channel | Major mediator of IP3-induced Ca2+ release in neurons and other cells |
| ITPR2 | IP3 receptor type 2 | Involved in exocrine secretion and cardiac function |
| ITPR3 | IP3 receptor type 3 | Highly expressed in pancreatic beta cells and immune cells |
| PLCB1 | Phospholipase C beta 1, produces IP3 | Upstream regulator of IP3 generation |
| PLCG1 | Phospholipase C gamma 1, produces IP3 | Links receptor tyrosine kinases to IP3 production |
| IP3K | Inositol 1,4,5-trisphosphate kinase, metabolizes IP3 | Terminates IP3 signal by converting it to IP4 |
| CALM1 | Calmodulin, regulates IP3 receptors | Modulates IP3 receptor activity in a Ca2+-dependent manner |
| ATP2A2 | SERCA2, pumps Ca2+ back into ER | Controls ER Ca2+ load and IP3 sensitivity |
| RYR1 | Ryanodine receptor 1 | Mediates calcium-induced calcium release, crosstalk with IP3 receptors |
| PRKACA | Protein kinase A catalytic subunit | Phosphorylates IP3 receptors, modulating IP3 binding |
| PRKCA | Protein kinase C alpha | Phosphorylates IP3 receptors, affecting channel activity |
| AKT1 | Protein kinase B | Phosphorylates IP3 receptors, involved in cell survival |
| BCL2 | Anti-apoptotic protein | Interacts with IP3 receptors to regulate apoptosis |
| HSPA5 | GRP78, ER chaperone | Assists in IP3 receptor folding and stability |
| TRPC3 | Transient receptor potential channel C3 | Contributes to Ca2+ entry following IP3-induced depletion |
| ORAI1 | Calcium release-activated calcium channel protein 1 | Mediates store-operated Ca2+ entry after IP3-induced depletion |
| STIM1 | Stromal interaction molecule 1 | Senses ER Ca2+ depletion and activates ORAI1 |
How Is inositol 1,4,5 trisphosphate binding Regulated?
IP3 binding and IP3 receptor function are regulated at multiple levels. The binding affinity for IP3 can be modulated by intracellular ATP, which enhances channel activity. Calcium itself exerts biphasic regulation, with low concentrations potentiating IP3 binding and high concentrations inhibiting it. Phosphorylation by protein kinases such as PKA, PKC, and Akt modulates receptor sensitivity and channel gating. Additionally, interacting proteins like Bcl-2 and calmodulin can influence IP3 binding and channel opening. These regulatory mechanisms ensure that calcium signals are appropriately shaped in response to physiological demands.
inositol 1,4,5 trisphosphate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITPR1 | Spinocerebellar ataxia, neurodegeneration | Knockout and point-mutation cell models |
| ITPR3 | Cancer progression, immune disorders | Overexpression and knockout cell lines |
| ITPR2 | Cardiac hypertrophy, exocrine dysfunction | Knock-in and knockout models |
| PLCB1 | Epilepsy, cancer | Knockout and point-mutation models |
| BCL2 | Lymphoma, apoptosis resistance | Knock-in and overexpression models |
Cancer
Altered IP3 receptor expression and IP3 binding have been observed in various cancers, where they contribute to enhanced proliferation, migration, and resistance to apoptosis. For example, ITPR3 is overexpressed in some cancers and promotes tumor growth. Targeting IP3 binding may offer therapeutic opportunities.
Neurodegenerative disorders
Dysregulated IP3-mediated calcium release is implicated in Alzheimer's disease, Huntington's disease, and other neurodegenerative conditions. In Huntington's disease, mutant huntingtin sensitizes IP3 receptors to IP3, leading to excessive calcium release and neuronal death. Modulating IP3 binding could be neuroprotective.
Cardiovascular diseases
IP3 receptors play critical roles in cardiac hypertrophy and arrhythmias. Altered IP3 binding and signaling contribute to pathological cardiac remodeling. Targeting IP3 receptors is being explored for heart failure treatment.
From inositol 1,4,5 trisphosphate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ITPR1 affect IP3-induced calcium release? | ITPR1 knockout cell line |
| How does a disease-associated point mutation alter IP3 binding affinity? | Point-mutation knock-in cell line |
| Can a tagged ITPR1 be used to track IP3 receptor localization? | Tagged knock-in cell line |
| Does overexpression of ITPR3 promote cancer cell proliferation? | ITPR3 overexpression cell line |
| What is the role of ITPR2 in cardiac hypertrophy? | ITPR2 knockout and knock-in models |
| Can CRISPR library screening identify modifiers of IP3 signaling? | Genome-wide CRISPR knockout library screening |
How to Study the inositol 1,4,5 trisphosphate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent ligand binding assay | IP3 binding affinity and kinetics | Compound screening, receptor characterization |
| Calcium imaging | Intracellular Ca2+ concentration changes | Functional analysis of IP3-induced Ca2+ release |
| Affinity chromatography | IP3-binding protein isolation | Purification of IP3 receptors and novel binders |
| CRISPR knockout screening | Gene essentiality for IP3 signaling | Discovery of regulators of IP3 binding |
| RNA-seq | Transcriptional changes upon IP3 signaling | Pathway analysis in knockout models |
| Proteomics | Protein interactions and modifications | Identification of IP3 receptor complexes |
| Patch-clamp electrophysiology | Ion channel activity | Direct measurement of IP3 receptor channel gating |
Fluorescent ligand binding assays
Competitive fluorescent ligand assays using IP3 derivatives allow quantitative measurement of IP3 binding affinity and kinetics in live cells or membrane preparations. These assays are useful for screening compounds that modulate IP3 binding.
Calcium imaging
Calcium imaging with fluorescent indicators such as Fura-2 or GCaMP enables real-time monitoring of IP3-induced Ca2+ release in cells. This method is essential for studying the functional consequences of IP3 binding.
Affinity chromatography
IP3 affinity chromatography can purify IP3-binding proteins from cell lysates, allowing identification and characterization of novel IP3-binding proteins.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate IP3 binding and downstream calcium signaling. These screens are powerful for discovering new components of the pathway.
How CRISPR Can Be Used to Study GO:0070679 inositol 1,4,5 trisphosphate binding
Knockout
CRISPR knockout of IP3 receptor genes (ITPR1, ITPR2, ITPR3) in cell lines abolishes IP3-induced calcium release, providing a clean background to study the specific contributions of each isoform. Knockout models are also used to validate drug targets and to dissect downstream signaling pathways.
Point Mutation
Introducing disease-associated point mutations into IP3 receptor genes via CRISPR allows researchers to study how specific amino acid changes affect IP3 binding affinity, channel gating, and cellular physiology. For example, mutations in the IP3-binding domain can alter ligand sensitivity and contribute to disease phenotypes.
Knock-in
Knock-in of tagged IP3 receptors (e.g., GFP or HA tags) enables real-time imaging and biochemical isolation of receptor complexes. Knock-in of reporter genes under the control of IP3 receptor promoters can be used to monitor expression dynamics.
Overexpression
Overexpression of wild-type or mutant IP3 receptors in cell lines is used to study gain-of-function effects, such as enhanced calcium release and downstream signaling. Overexpression models are valuable for drug screening and for studying receptor regulation.
How EDITGENE Supports inositol 1,4,5 trisphosphate binding Research
Researchers studying inositol 1,4,5 trisphosphate binding-related genes often need to determine whether a candidate gene is causally involved in calcium signaling, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for inositol 1,4,5 trisphosphate binding research.
Frequently Asked Questions About inositol 1,4,5 trisphosphate binding
What is inositol 1,4,5 trisphosphate binding?
Inositol 1,4,5 trisphosphate (IP3) binding is a molecular function (GO:0070679) where a protein selectively binds IP3, a second messenger that triggers calcium release from intracellular stores.
What genes are involved in inositol 1,4,5 trisphosphate binding?
The main genes are ITPR1, ITPR2, and ITPR3, which encode IP3 receptors. Other genes like PLCB1 and PLCG1 produce IP3, while IP3K metabolizes it.
How does IP3 binding lead to calcium release?
IP3 binding induces a conformational change in IP3 receptors, opening a calcium channel in the endoplasmic reticulum and allowing Ca2+ to flow into the cytoplasm.
What diseases are associated with IP3 binding?
Dysregulated IP3 binding is linked to cancer, neurodegenerative disorders (e.g., Alzheimer's, Huntington's), and cardiovascular diseases.
What is the GO term for IP3 binding?
The Gene Ontology term is GO:0070679, defined as binding to inositol 1,4,5 trisphosphate.
How can I study IP3 binding in the lab?
Common methods include fluorescent ligand binding assays, calcium imaging, affinity chromatography, and CRISPR-based genetic screens.
What are the synonyms for inositol 1,4,5 trisphosphate binding?
Synonyms include InsP3 binding and IP3 binding.
Which proteins contain an IP3-binding domain?
IP3 receptors (ITPR1-3) contain a conserved N-terminal IP3-binding domain. Some other proteins may also bind IP3.
How is IP3 binding regulated?
IP3 binding is regulated by ATP, calcium, phosphorylation, and interacting proteins such as calmodulin and Bcl-2.
Can CRISPR be used to study IP3 binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of IP3 binding mechanisms and their physiological roles.
Conclusion
Inositol 1,4,5 trisphosphate binding (GO:0070679) is a fundamental molecular function that initiates calcium signaling cascades critical for numerous cellular processes. The IP3 receptors (ITPR1-3) are the primary mediators of this function, and their regulation is complex, involving multiple cofactors and post-translational modifications. Dysregulation of IP3 binding contributes to cancer, neurodegeneration, and cardiovascular diseases, making it an attractive therapeutic target. CRISPR-based cell models provide powerful tools to study IP3 binding in health and disease, and EDITGENE offers comprehensive services to support such research.
References
- 1. Bezprozvanny I. 2005. The inositol 1,4,5-trisphosphate receptors.. Cell Calcium 38(3-4):261-72 PMID: 16102823
- 2. Putney JW Jr. 1987. Formation and actions of calcium-mobilizing messenger, inositol 1,4,5-trisphosphate.. Am J Physiol 252(2 Pt 1):G149-57 PMID: 3030126
- 3. Hirata M et al.. 1990. Inositol 1,4,5-trisphosphate affinity chromatography.. Biochem Biophys Res Commun 168(1):379-86 PMID: 2328011
- 4. Tanimura A et al.. 2020. Competitive Fluorescent Ligand Assay for Inositol 1,4,5-Trisphosphate.. Methods Mol Biol 2091:137-144 PMID: 31773577
- 5. Marshall IC et al.. 1993. Regulation of inositol 1,4,5-trisphosphate receptors.. J Exp Biol 184:161-82 PMID: 8270854
- 6. Ivanova H et al.. 2014. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.. Biochim Biophys Acta 1843(10):2164-83 PMID: 24642269
- 7. Márquez-Moñino MÁ et al.. 2024. Substrate promiscuity of inositol 1,4,5-trisphosphate kinase driven by structurally-modified ligands and active site plasticity.. Nat Commun 15(1):1502 PMID: 38374076
- 8. Michikawa T et al.. 1996. Inositol 1,4,5-trisphosphate receptors and calcium signaling.. Crit Rev Neurobiol 10(1):39-55 PMID: 8853953
